BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 20455788)

  • 1. Integrating clinical trial findings into practice through risk stratification: the case of heart failure management.
    Smith DH; Johnson ES; Thorp ML; Crispell KA; Yang X; Petrik AF
    Popul Health Manag; 2010 Jun; 13(3):123-9. PubMed ID: 20455788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hospital cost effect of a heart failure disease management program: the Specialized Primary and Networked Care in Heart Failure (SPAN-CHF) trial.
    Gregory D; Kimmelstiel C; Perry K; Parikh A; Konstam V; Konstam MA
    Am Heart J; 2006 May; 151(5):1013-8. PubMed ID: 16644325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of integrated community nursing services on hospital utilization and costs in a Medicare risk plan.
    Burns LR; Lamb GS; Wholey DR
    Inquiry; 1996; 33(1):30-41. PubMed ID: 8774372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting risk of hospitalization or death among patients with heart failure in the veterans health administration.
    Wang L; Porter B; Maynard C; Bryson C; Sun H; Lowy E; McDonell M; Frisbee K; Nielson C; Fihn SD
    Am J Cardiol; 2012 Nov; 110(9):1342-9. PubMed ID: 22819429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized, controlled evaluation of short- and long-term benefits of heart failure disease management within a diverse provider network: the SPAN-CHF trial.
    Kimmelstiel C; Levine D; Perry K; Patel AR; Sadaniantz A; Gorham N; Cunnie M; Duggan L; Cotter L; Shea-Albright P; Poppas A; LaBresh K; Forman D; Brill D; Rand W; Gregory D; Udelson JE; Lorell B; Konstam V; Furlong K; Konstam MA
    Circulation; 2004 Sep; 110(11):1450-5. PubMed ID: 15313938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Edema index established by a segmental multifrequency bioelectrical impedance analysis provides prognostic value in acute heart failure.
    Liu MH; Wang CH; Huang YY; Tung TH; Lee CM; Yang NI; Liu PC; Cherng WJ
    J Cardiovasc Med (Hagerstown); 2012 May; 13(5):299-306. PubMed ID: 22367574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving outcomes in heart failure in the community: long-term survival benefit of a disease-management program.
    Akosah KO; Schaper AM; Haus LM; Mathiason MA; Barnhart SI; McHugh VL
    Chest; 2005 Jun; 127(6):2042-8. PubMed ID: 15947318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic implications of extended-release metoprolol succinate for heart failure in the MERIT-HF trial: a US perspective of the MERIT-HF trial.
    Caro JJ; Migliaccio-Walle K; O'Brien JA; Nova W; Kim J; Hauch O; Hillson E; Wedel H; Hjalmarson A; Gottlieb S; Deedwania PC; Wikstrand J;
    J Card Fail; 2005 Dec; 11(9):647-56. PubMed ID: 16360958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in intrathoracic impedance are associated with subsequent risk of hospitalizations for acute decompensated heart failure: clinical utility of implanted device monitoring without a patient alert.
    Small RS; Wickemeyer W; Germany R; Hoppe B; Andrulli J; Brady PA; Labeau M; Koehler J; Sarkar S; Hettrick DA; Tang WH
    J Card Fail; 2009 Aug; 15(6):475-81. PubMed ID: 19643357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic importance of elevated jugular venous pressure and a third heart sound in patients with heart failure.
    Drazner MH; Rame JE; Stevenson LW; Dries DL
    N Engl J Med; 2001 Aug; 345(8):574-81. PubMed ID: 11529211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenges of subgroup analyses in multinational clinical trials: experiences from the MERIT-HF trial.
    Wedel H; Demets D; Deedwania P; Fagerberg B; Goldstein S; Gottlieb S; Hjalmarson A; Kjekshus J; Waagstein F; Wikstrand J;
    Am Heart J; 2001 Sep; 142(3):502-11. PubMed ID: 11526365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depression predicts repeated heart failure hospitalizations.
    Johnson TJ; Basu S; Pisani BA; Avery EF; Mendez JC; Calvin JE; Powell LH
    J Card Fail; 2012 Mar; 18(3):246-52. PubMed ID: 22385946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of eplerenone at different levels of risk in patients with systolic heart failure and mild symptoms: insight from a novel risk score for prognosis derived from the EMPHASIS-HF trial.
    Collier TJ; Pocock SJ; McMurray JJ; Zannad F; Krum H; van Veldhuisen DJ; Swedberg K; Shi H; Vincent J; Pitt B
    Eur Heart J; 2013 Sep; 34(36):2823-9. PubMed ID: 23864130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The estimated costs and savings of medical nutrition therapy: the Medicare population.
    Sheils JF; Rubin R; Stapleton DC
    J Am Diet Assoc; 1999 Apr; 99(4):428-35. PubMed ID: 10207394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology and risk stratification in acute heart failure.
    Fonarow GC
    Am Heart J; 2008 Feb; 155(2):200-7. PubMed ID: 18215587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative potential of the 2-item versus the 9-item patient health questionnaire to predict death or rehospitalization in heart failure.
    Piepenburg SM; Faller H; Gelbrich G; Störk S; Warrings B; Ertl G; Angermann CE
    Circ Heart Fail; 2015 May; 8(3):464-72. PubMed ID: 25878325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Refractory heart failure. Models of hospital, ambulatory, and home management].
    Oliva F; Alunni G
    Ital Heart J Suppl; 2002 Aug; 3(8):837-50. PubMed ID: 12407839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of older patients with heart failure who may be candidates for hospice care: development of a simple four-item risk score.
    Huynh BC; Rovner A; Rich MW
    J Am Geriatr Soc; 2008 Jun; 56(6):1111-5. PubMed ID: 18482294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two-year outcome of a prospective, controlled study of a disease management programme for elderly patients with heart failure.
    Del Sindaco D; Pulignano G; Minardi G; Apostoli A; Guerrieri L; Rotoloni M; Petri G; Fabrizi L; Caroselli A; Venusti R; Chiantera A; Giulivi A; Giovannini E; Leggio F
    J Cardiovasc Med (Hagerstown); 2007 May; 8(5):324-9. PubMed ID: 17443097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multinational economic evaluation of valsartan in patients with chronic heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT).
    Reed SD; Friedman JY; Velazquez EJ; Gnanasakthy A; Califf RM; Schulman KA
    Am Heart J; 2004 Jul; 148(1):122-8. PubMed ID: 15215801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.